Intensive metabolic support: Evolution and revolution

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 1047-1054

  Scurlock, Corey ^a   Raikhelkar, Jayashree ^a   Mechanick, Jeffrey I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CONVALESCENCE; HEALTH CARE COST; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; MEDICAL SPECIALIST; MEDLINE; METABOLIC REGULATION; MORTALITY; NUTRITION; REVIEW; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; METHODOLOGY; NUTRITIONAL SUPPORT;

BLOOD GLUCOSE; CRITICAL CARE; HUMANS; INSULIN; NUTRITIONAL SUPPORT;

EID: 65849114748     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.1047     Document Type: Review

References (45)

1. Hollander JM, Mechanick JI. Nutrition support and the chronic critical illness syndrome. Nutr Clin Pract. 2006;21:587-604.
2. Langouche L, Van den Berghe G. The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am. 2006;35:777-791.
3. Weigent DA, Blalock JE. Associations between the neuroendocrine and immune systems. J Leukoc Biol. 1995;58:137-150.
4. Weigent DA, Blalock JE. Production of peptide hormones and neurotransmitters by the immune system. Chem Immunol. 1997;69:1-30.
5. Chemical Immunology. vol 52, 2nd ed. In: JE Blalock, ed. Neuroimmunoendocrinology. Vol. 52, 2nd ed. Switzerland: S Karger AG, Basel; 1992: 1-19.
6. Laterre PF, Abraham E, Janes JM, Trzaskoma BL, Correll NL, Booth FV. ADDRESS (Aministration of Drotrecogin Alfa [activated] in Early Stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation. Crit Care Med. 2007;35:1457-1463.
7. Vincent DL, Bernard GR, Beale R, et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global openlabel trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005;33:2266-2277.
8. Mechanick JI, Chiolero R. Special commentary: a call for intensive metabolic support. Curr Opin Clin Nutr Metab Care. 2008;11:666-670.
9. Gabbanelli V, Pantanetti S, Donati A, Principi T, Pelaia P. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol. 2005;71:717-725.
10. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006;34:96-101.
11. Mechanick JI, Handelsman Y, Bloomgarden ZT. Hypoglycemia in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2007;10:193-196.
12. Ceriello A, Giacomello R, Stel G, et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes. 1995;44:924-928.
13. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
14. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612-616.
15. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in medical ICU. N Engl J Med. 2006;354:449-461.
16. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348-1353.
17. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159.
18. Mehta SR, Yusuf S, Díaz R, et al; the CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
19. Malmberg K, Rydén L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
20. Bruckhorst F, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
21. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290: 2041-2047.
22. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients [erratum in Mayo Clin Proc. 2005;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
23. Vriesendorp TM, DeVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006;34:2714-2718.
24. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control: what is the evidence? Crit Care Med. 2007;35(Suppl 9):S496-S502.
25. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab. 2007;92:3890-3897.
26. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006;129:960-967.
27. Villet S, Chiolero RL, Bollmann, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005;24:502-509.
28. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P; Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003:27:355-373.
29. Aspen Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adults and pediatric patients: administration of specialized nutrition support. JPEN J Parenter Enteral Nutr. 2002;26:18S-21S.
30. Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr. 2002;26:174-181.
31. Dhaliwal R, Heyland DK. Nutrition and infection in the intensive care unit: what does the evidence show? Curr Opin Crit Care. 2005;11:461-467.
32. Debaveye Y, Van den Berghe G. Risks and benefits of nutritional support during critical illness. Annu Rev Nutr. 2006;26:513-538.
33. Scurlock C, Mechanick JI. Early nutrition support in the intensive care unit: a US perspective. Curr Opin Clin Nutr Metab Care. 2008;11:152-155.
34. Bauer P, Charpentier C, Bouchet C, Nace L, Raffy F, Gaconnet N. Parenteral with enteral nutrition in the critically ill. Intensive Care Med. 2000;26:893-900.
35. Nelson JE, Meier DE, Litke A, Natale DA, Siegel RE, Morrison RS. The symptom burden of chronic critical illness. Crit Care Med. 2004;32:1527-1534.
36. Mechanick JI, Brett EM. Nutrition support of the chronically critically ill patient. Crit Care Clin. 2002;18:597-618.
37. Nierman DM, Mechanick JI. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest. 2000;118;761-766.
38. Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest. 1998;114:1122-1128.
39. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88:4623-4632.
40. Goldberg M, Mechanick JI, Nierman DM. Thyroid function and outcomes in chronic critical illness. Abstract presented at: the American Association of Clinical Endocrinologists 13th Annual Meeting and Clinical Congress: April 28-May 2, 2004; Boston, MA.
41. Datta D, Scalise P. Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center. Chest. 2004;126:1307-1312.
42. Potestà P, Murolo R, Costantini S, et al. High prevalence of asymptomatic hypothyroidism and hyperthyroidism in hospitalized elderly females. Riv Eur Sci Med Farmacol. 1996;18:129-133.
43. De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006;22:57-86.
44. Mebis L, Debaveye Y, Visser TJ, Van den Berghe G. Changes within the thyroid axis during the course of critical illness. Endocrinol Metab Clin North Am. 2006;35:807-821.
45. Multz AS, Chalfin DB, Samson IM, et al. A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICU. Am J Respir Crit Care Med. 1998;157:1468-1473.